ADENOCAP
Dead / Abandoned — Abandoned — no statement of use filed (as of 17 Jun 2024)
What this means for you
This application is over — abandoned 17 Jun 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90047807
- Mark type
- Stylized text
- Filed
- 10 Jul 2020
- Published for opposition
- 16 Mar 2021
- Abandoned
- 17 Jun 2024
- Attorney of record
- Michael J. McCue
Goods and services
- Class 042 — Scientific and technological services: Scientific research services for the prevention, diagnosis, and treatment of COVID-19 and human adenovirus infections; development of pharmaceuticals, diagnostics, vaccines and therapeutics for COVID-19 and human adenovirus infections; scientific research services for adenovirus vectors for gene therapy, vaccines and cancer therapy
Owner
- NANTCELL, INC., CULVER CITY, CA, US
- ImmunityBio, Inc., Culver City, CA, US
- ImmunityBio, Inc., Culver City, CA, US
Prosecution history
- 12 Jul 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 17 Jun 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 23 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Nov 2023 — SOU EXTENSION 5 GRANTED
- 13 Nov 2023 — SOU EXTENSION 5 FILED
- 13 Nov 2023 — SOU TEAS EXTENSION RECEIVED
- 10 May 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 May 2023 — SOU EXTENSION 4 GRANTED
- 08 May 2023 — SOU EXTENSION 4 FILED
- 08 May 2023 — SOU TEAS EXTENSION RECEIVED
- 15 Nov 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Nov 2022 — SOU EXTENSION 3 GRANTED
- 11 Nov 2022 — SOU EXTENSION 3 FILED
- 11 Nov 2022 — SOU TEAS EXTENSION RECEIVED
- 30 Jun 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED